The company distributes products across four channels: E-commerce, Brick & Mortar retailers, Direct to Consumer via its website, and International partnerships. Following the merger closing in 2025, the legacy BTTR stock ticker was retired in favor of SRXH, and the company executed a spin-out of its Halo business assets to provide separate value to existing shareholders.
Cyborg Score Rationale
Like many emerging wellness companies, Better Choice has navigated periods of negative net income while scaling its operations. The company's strategic pivot to healthcare and divestiture of Asian pet operations signals a shift toward profitability, though current market capitalization remains modest.
Top Insights
Merged with SRx Health Solutions in 2024-2025 to pivot from pet wellness to specialty pharmacy and healthcare services
Transitioned from BTTR to SRXH ticker and spun out Halo brand as separate entity to unlock shareholder value
Divested Halo's Asia business while retaining key North American operations to focus on core markets
SRx Health reported over CAD$200 million in annual revenue with over 20% year-over-year growth expected to continue in fiscal 2025
Named Competitors
Hill's Science Diet — Premium prescription and science-based pet nutrition
Royal Canin — Premium specialized pet food brands
Purina Pro Plan — Mass-market premium pet nutrition
Recent Developments
(Early 2025) Completed merger with SRx Health Solutions and transitioned from BTTR to SRXH ticker
(April 2025) Distributed Halo spin-out to shareholders and issued stock dividends
(2024) Agreed to sell Halo's Asia business for $8.1 million in gross proceeds
Open the full interactive Better Choice Company Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.